Burzynski: Cancer Is Serious Business, Part II

Burzynski: Cancer Is Serious Business, Part II

Release date : March 1, 2013
Runtime : 1h 47m
Countries of origin :
Original Language : English /
Director : Eric Merola /
Writers :
Production companies :
March 1, 2013 1h 47m Documentary English More
8.8
User Score

Overview

In the compelling follow-up to the internationally award-winning documentary, "Burzynski: the Movie,", Part II explores the current status of Antineoplastons' clinical testing sanctioned by the United States Food & Drug Administration - and features a modern story of the struggling journeys of cancer patients being treated today at the Burzynski Clinic in Houston, Texas. Since the mapping of the Cancer Genome, Burzynski has pioneered an expansion of his therapy, which he calls, "Personalized Gene-Targeted Cancer Therapy", where each patient's Genomic Cancer Atlas is mapped and a treatment regimen is personally tailored for each individual patient - vs. the conveyor belt, "one-size-fits-all" approach that current oncology adheres to.
More »

Top Billed Cast

More

Images

View All Images

Recommendations

More
Kingdom 2: Far and Away
Action Adventure War
Qwerty
Animation Drama Family
Ambush
War Action Thriller
Noryang: Deadly Sea
Action History Drama War
Gamera vs. Barugon
Fantasy Action Science Fiction
Article 20
Drama Comedy Family
  • title:Burzynski: Cancer Is Serious Business, Part II
  • status:Released
  • Release date: 2013
  • Runtime:1h 47m
  • Genres: Documentary ·
  • Countries of origin:
  • Original Language: English ·
  • Director: Eric Merola /
  • Writers:
  • Production companies:
  • Overview:In the compelling follow-up to the internationally award-winning documentary, "Burzynski: the Movie,", Part II explores the current status of Antineoplastons' clinical testing sanctioned by the United States Food & Drug Administration - and features a modern story of the struggling journeys of cancer patients being treated today at the Burzynski Clinic in Houston, Texas. Since the mapping of the Cancer Genome, Burzynski has pioneered an expansion of his therapy, which he calls, "Personalized Gene-Targeted Cancer Therapy", where each patient's Genomic Cancer Atlas is mapped and a treatment regimen is personally tailored for each individual patient - vs. the conveyor belt, "one-size-fits-all" approach that current oncology adheres to.
Search history
delete
Popular search